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Some previously synthesized (perÑuoroalkyl)alkyldimorpholinophosphates, C
n
F2n`1CmH2mOP(O)-
were found remarkably to stabilize heat sterilizable water-in-Ñuorocarbon reverse[N(CH2CH2)2O]2 ,
emulsions and to have a strong proclivity to self-aggregate into microtubular assemblies when dispersed in
water. This series has now been extended in order to allow structureÈproperty relationships to be
established and product optimization to be achieved. A new series of even more Ñuorophilic compounds
consisting in bis[(perÑuoroalkyl)alkyl]monomorpholinophosphates, (C
n
F2n`1CmH2mO)2P(O)N(CH2CH2)2O,
was also synthesized. Preliminary surfactant activity and biocompatibility data are presented and
compared to data obtained with non-Ñuorinated analogues.
There is a need for novel, highly e†ective and biocompatible
surfactants to serve as components of drug preparation and
delivery systems. A large variety of well-deÐned pure per-
Ñuoroalkylated amphiphiles have been synthesized in recent
years with this objective in mind1h4 and were investigated as
emulsion stabilizers, vesicle-forming components and for other
uses.5,6 Among the most Ñuorophilic neutral compounds
synthesized were some (perÑuoroalkyl)alkyldimorpho-
linophosphates, C
n
F2n`1CmH2mOP(O)[N(CH2CH2)2O]2 ,(FnCmDMPs).7
Investigation of this initial series of compounds revealed
several unexpectedly interesting features, including : (i) a
remarkable capacity to allow the preparation and stabiliza-
tion of water-in-Ñuorocarbon reverse emulsions ; these emul-
sions, which were stable enough to withstand heat
sterilization, could be loaded with a variety of drugs and other
agents, and have potential in drug delivery through the pul-
monary route ;8 (ii) a remarkable tendency to self-aggregate
when dispersed in water and to yield sturdy, regularly shaped,
long microtubules in which the surfactant molecules appear to
be highly ordered ;9,10 when heated, these tubules reversibly
convert into giant vesicles. When hydrocarbon analogues were
dispersed in water no aggregates larger than micelles were
seen, in line with the usual behaviour of single-chain amphi-
philes ; (iii) low acute toxicities, whether when administered
intraperitoneally or intravascularly, as well as the absence of
hemolytic activity in spite of their high surface activity. By
contrast, the hydrogen analogues are highly hemolytic.
A more extensive series of dimorpholinophosphates was
needed in order to optimize and establish these results on a
Ðrmer basis and to determine structureÈproperty relation-
ships. Compounds with higher and lower Fn : Cm ratios
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were synthesized as well as compounds with intermediate
hydrocarbon spacer lengths, since such intermediate spacer
lengths were shown to have an inÑuence on the ordering
of the surfactant Ðlms.11 In addition, the synthesis of even
more Ñuorophilic compounds, with two perÑuoroalkyl
chains, was decided upon. These compounds consist
in the bis(perÑuoroalkyl)alkylmonomorpholinophosp-
hates, code-named(C
n
F2n`1CmH2mO)2P(O)N(CH2CH2)2O,D(FnCm)MMP. Some hydrogenated analogues were also pre-
pared in order to determine the impact of the Ñuorinated
chains on the amphiphilesÏ behaviour.
This paper describes the synthesis of the new F-alkylated
mono- and dimorpholinophosphates, their characterization
and a preliminary assessment of their surface activity and bio-
compatibility.
Experimental
Materials and methods
The perÑuoroalkylated alcohols and iodides utilized were a
gift from Atochem (Pierre-Be nite, France) or were synthesized
as described below. They were recrystallised from chloroform
or distilled under reduced pressure prior to use. The alcohols
with a longer hydrocarbon spacer were synthesized according
to Brace by radical addition of to terminally unsatu-C
n
F2n`1Irated alcohols followed by reductionCH2xCH(CH2)m~2OH,with HClÈZn in anhydrous ethanol.12 (F-Heptyl)methanol,
was prepared from the methyl per-C7F15CH2OH,Ñuorooctanoate ester by reduction inC7F15COOCH3 NaBH4isopropanol.13 Synthesis of the (F-alkyl)propanols is described
elsewhere.14 Phosphorus oxytrichloride, triethylamine and
morpholine (Aldrich) were distilled prior to use. Per-
Ñuorodecalin (FDC) was a gift from Air Products (USA).
TLC analyses were performed on RP-18 silica gel F-254
plates (Merck). Silica gel (70È230 mesh, Merck) was used for
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column chromatography. Melting points (uncorrected) were
determined with a Reichert apparatus. IR spectra were record-
ed on a Bruker IFS 45 and NMR spectra on a Bruker AC 200
spectrometer (the FT-IR and NMR spectra of F6C3DMP,
F7C1DMP, F8C3DMP and F10C3DMP were recorded on
Bruker IFS 55 and Bruker 500 MHz spectrometers by Dr. A.
Csa mpai, Hungary). The elemental analyses were performed
by the Service Central de Microanalyses of the Centre Nation-
al de la Recherche ScientiÐque (Lyon, France). Surface ten-
sions, and interfacial tensions, were measured with ancs , ci ,automatic Lauda tensiometer (platinum ring, Lecomte du
Nou y method) : aqueous solutions of the amphiphiles were
prepared using deionized water (Elgastat UHQ system, cs\mN m~1, and water/FDC\ 56 mN m~1). Tension72 civalues were obtained after careful equilibration of the inter-
face. Critical micellar concentrations (cmc) were estimated
from the well-marked breaking points of the C curves.csÈlog
Biological tests
In a typical cell culture test,15 ten Ñasks were Ðlled with 2 mL
of a suspension of Namalva lymphoblastoid cells in aN1nutrient medium; 2 mL of a 0.9% NaCl solution of the per-
Ñuoroalkylated surfactant to be tested, or 2 mL of physiologi-
cal water for the control series, was then added. After three
days of incubation, the number of cells were counted and(N2)their viability determined by the Trypon Blue dye exclusion
method : results were expressed as the ratio of living (non-
colored) cells to the total number of cells.
The hemolytic activity was evaluated on human red blood
cells according to ref. 16 : 2 mL of a 1% suspension of human
red blood cells were incubated for 1 h at 37 ¡C with 2 mL of a
0.9% NaCl solution of the surfactant to be tested. DetoxiÐed
water and physiological water were submitted to the same
procedure and taken as a positive reference and a blank,
respectively. After centrifugation, the optical density (OD) of
the supernatant was measured at 540 nm and the percentage
of hemolysis relative to detoxiÐed water was calculated
according to the relationship : 100(ODtest[ ODNaCl)/(ODH2O[ ODNaCl).The in vivo test consisted in injecting 0.5 mL of an isotonic
solution of the surfactant to be tested into the tail vein
(intravenous administration, i.v.) of 10 Dawley mice, weighing
20È25 g. Intraperitoneal administration (i.p) was achieved
with a solution of surfactant in detoxiÐed perÑuorooctyl
bromide. Growth, behaviour and any symptoms of intoxi-
cation of the animals were monitored over a period of one
month and compared to those of a reference population of
mice injected with the same volume of saline.
Synthesis of the (perÑuoroalkyl)alkyldimorpholinophosphates,
FnCmDMPs
[2-(F-Butyl)ethyl ]dimorpholinophosphate, F4C2DMP. 2-(F-
Butyl)ethanol (10.14 g, 38.4 mmol) and 14 mL of triethylamine
(2.5 equiv) were dissolved in 50 mL of dry ether and added
dropwise, at 0 ¡C and under anhydrous nitrogen, to 5.9 g (38.5
mmol) of phosphorus oxytrichloride in 70 mL of ether. The
mixture was stirred at 0 ¡C for 1 h. [2-(F-Butyl)ethoxy]phos-
phoryl dichloride was identiÐed as the major product ([90%)
of the reaction : 1H NMR (d, 2.57 (tt, 2H,CDCl3) : 3JHH \ 5.5Hz, Hz, 4.3 (dt, 2H, Hz,3JHF \ 18 RFCH2), 3JHH \ 5.5Hz, 31P NMR (d, [6.1, signal3JHP\ 7 CH2OP) ; CDCl3) :from by-product bis[2-(F-Butyl)ethoxy]phosphoryl mono-
chloride : d \ [10, less than 10% of the total signal area.
A solution of 6.68 g (76.7 mmol) of morpholine and 28 mL
(2.5 equiv) of triethylamine in 50 mL of ether was then added
dropwise to the stirred reaction mixture, which was main-
tained free from oxygen and cooled with an ice-bath. After
stirring for 18 h, the mixture was allowed to warm up to room
temperature, triethylamine hydrochloride was Ðltered o†, and
the solvent and excess of amine were removed under vacuum.
The clear oily residue was dried under reduced pressure and
puriÐed by chromatography (ethyl acetateÈmethanol 9 : 1),
leading to 12.65 g of the Ðnal product (69% with respect to the
alcohol). Purity was controlled by TLC value\ 0.7, ethyl(RfacetateÈmethanol 9 : 1, 1% Ñuorescein in ethanol solution
spray) ; GC: 99.7%. MW \ 482 g, liquid at 25 ¡C. 1H NMR (d,
TMS ref., 2.5 (tt, 2H, Hz, Hz,CDCl3) : 3JHH \ 5.6 3JHF\ 20.23.1 (td, 8H, Hz, Hz, 3.6RFCH2), 3JHH \ 5.0 3JHP \ 3.7 NCH2),(t, 8H, Hz, 4.2 (td, 2H, Hz,3JHH \ 5.1 CH2OCH2), 3JHH \ 6.0Hz, 19F NMR (d, ref.,3JHP\ 7.6 CH2OP) ; CFCl3 CDCl3) :[81.5 [114.3 [125.0(CF3), (CF2CH2), (CF3CF2CF2),[126.5 13C NMR (d, TMS ref., 32.1 (td,(CF3CF2) ; CDCl3) :Hz, Hz, 44.6 (s, 57.22JCF\ 21.5 3JCP \ 7.1 RFCH2), NCH2),(d, Hz, 67.1 (d, Hz,2JPC\ 4.2 CH2OP), 3JCP\ 6.531P NMR (d, ref., 14.1 ; IR (m/CH2OCH2) ; H3PO4 CDCl3) :cm~1) : 1250È1180 (PxO, CF), 971 (PN). Anal. calcd (%) for
C 34.85 ; H 4.15 ; N 5.81, P 6.43 ; found CC14H20F9N2O4P:34.64 ; H 4.13 ; N 5.73 ; P 6.29.
The same procedure was applied for the synthesis of all
dimorpholinophosphates using the quantities mentioned
below.
[3-(F-Hexyl)propyl ]dimorpholinophosphate, F6C3DMP.
3-(F-Hexyl)propanol (21.2 mmol), 21.2 mmol of and 53OPCl3mmol of morpholine. Yield\ 69% after chromatography
(etherÈchloroformÈmethanol 4.5 : 5 : 0.5) and recrystallisation
in isooctane. MW \ 596 g, m.p.\ 40 ¡C. 1H NMR (d,
1.9 (m, 2H, 2.1 (m, 2H, 3.1 (td,CDCl3) : RFCH2), RFCH2CH2),8H, Hz, Hz, 3.6 (t, 8H,3JHH \ 6.6 3JHP\ 6.7 NCH2), 3JHH \Hz, 4.0 (td, 2H, Hz, Hz,6.3 CH2OCH2), 3JHH \ 7.8 3JHP \ 9.813C NMR (d, 21.9 (s, 27.7 (t,CH2OP). CDCl3) : RFCH2),44.8 (s, 63.9 (d, Hz,RFCH2CH2) NCH2), 2JCP\ 5.0 CH2OP),67.2 (d, Hz, 31P NMR (d,3JCP\ 5.5 CH2OCH2). CDCl3) :14.8.
[1-(F-Heptyl)methyl ]dimorpholinophosphate, F7C1DMP.
1-(F-Heptyl)methanol (10.0 mmol), 10.0 mmol of andPOCl325 mmol of morpholine. Yield\ 60%. MW\ 618 g,
m.p.\ 49 ¡C. 1H NMR (d, 3.1 (td, 8H, Hz,CDCl3) : 3JHH \ 5.0Hz, 3.7 (t, 8H, Hz,3JHP\ 5.8 NCH2), 3JHH \ 4.5 CH2OCH2),4.4 (td, 2H, Hz, Hz, 13C3JHH \ 6.7 3JHP \ 13.3 CH2OP).NMR (d, 44.7 (s, 61.7 (t, 67.1 (s,CDCl3) : NCH2), CH2OP),31P NMR (d, 15.5. IR (m/cm~1) : 1240ÈCH2OCH2). CDCl3) :1210 (CF), 2890È2850 (CH), 974 (PN).
[3-(F-Octyl)propyl ]dimorpholinophosphate, F8C3DMP.
3-(F-Octyl)propanol (12.5 mmol), 12.5 mmol of andOPCl331.4 mmol of morpholine. Yield \ 64% after chromatography
(etherÈchloroformÈmethanol 4.5 : 5 : 0.5) and recrystallisation
in isooctane. MW \ 696 g, m.p.\ 59 ¡C. 1H NMR (d,
2.0 (m, 2H, 2.2 (m, 2H, 3.1 (td,CDCl3) : RFCH2), RFCH2CH2),8H, Hz, Hz, 3.6 (t, 8H,3JHH \ 6.6 3JHP\ 6.7 NCH2), 3JHH \Hz, 4.0 (td, 2H, Hz, Hz,6.3 CH2OCH2), 3JHH \ 7.8 3JHP \ 9.813C NMR (d, 21.9 (s, 27.7 (t,CH2OP). CDCl3) : RFCH2),44.8 (s, 63.9 (d, Hz,RFCH2CH2), NCH2), 2JCP \ 5.0 CH2OP),67.2 (d, Hz, 31P NMR (d,3JCP\ 5.5 CH2OCH2). CDCl3) :14.8.
[5-(F-Octyl)pentyl ]dimorpholinophosphate, F8C5DMP.
5-(F-Octyl)pentanol (32.6 mmol), 32.6 mmol of andOPCl370.4 mmol of morpholine. Yield\ 73%. MW\ 724 g ;
m.p.\ 78 ¡C. 1H NMR (d, 1.5 (s, 2H), 1.7 (m, 4H), 2.1CDCl3) :(tt, 2H, Hz, Hz, 3.1 (td, 8H,3JHH \ 6.2 3JHF \ 19.1 RFCH2),
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Hz, Hz, 3.6 (t, 8H,3JHH \ 6.1 3JHP \ 4.5 NCH2), 3JHH \ 6.1Hz, 3.9 (td, 2H, Hz, Hz,CH2OCH2), 3JHH \ 6.2 3JHP \ 6.919F NMR (d, [81.2 [114.8CH2OP). CDCl3) : (CF3),[122.3 (6F), [123.2 (2F), [123.9 (2F), [126.6(CF2CH2), 13C NMR (d, 20.1 (t, Hz,(CF3CF2). CDCl3) : 3JCF\ 5.525.5, 30.3 (s, 2 31.1 (t, Hz,RFCH2CH2), CH2), 2JCF\ 21.544.9 (s, 65.2 (d, Hz, 67.3RFCH2), NCH2), 2JCP\ 3.8 CH2OP),(d, Hz, 31P NMR (d, 13.7. IR3JCP \ 5.5 CH2OCH2). CDCl3) :(m/cm~1) : 1250È1150 (PxO, CF), 974 (PN), 2930È2850 (CH).
Anal. calcd (%) for C 34.81 ; H 3.59 ; NC21H26F17N2O4P:3.87 ; P 4.28 ; found : C 34.64 ; H 3.74 ; N 3.89 ; P 4.35.
[1-(F-Nonyl)methyl ]dimorpholinophosphate, F9C1DMP.
1-(F-Nonyl)methanol (8.8 mmol), 8.9 mmol of and 17.7OPCl3mmol of morpholine. Yield\ 71%. MW\ 718 g,
m.p.\ 67 ¡C. 1H NMR (d, 3.1 (td, 8H, Hz,CDCl3) : 3JHH \ 6.1Hz, 3.6 (t, 8H, Hz,3JHP\ 3.1 NCH2), 3JHH \ 6 CH2OCH2),4.4 (td, 2H, Hz, Hz, 19F3JHF\ 22.7 3JHP \ 7.5 CH2OP).NMR (d, [81.2 [120.7 [122.3CDCl3) : (CF3), (CF2CH2),(4F), [123.1 (2F), [123.5 (6F), [126.6 13C NMR(CF3CF2).(d, 44.8 (s, 61.8 (dt, Hz,CDCl3) : NCH2), 2JCF \ 20.0 2JCP\Hz, 67.1 (d, Hz, 31P4.0 CH2OP), 3JCP\ 5.5 CH2OCH2).NMR (d, 14.7. IR (m/cm~1) : 1250È1150 (PxO, CF),CDCl3) :976 (PN). Anal. calcd (%) for C 30.08 ; HC18H18F19N2O4P:2.52 ; N 3.9 ; P 4.32 ; found : C 30.21, H 2.34 ; N 3.85 ; P 4.38.
[2-(F-Decyl)ethyl ]dimorpholinophosphate, F10C2DMP.
2-(F-Decyl)ethanol (18.4 mmol), 18.4 mmol of and 36.9OPCl3mmol of morpholine. Yield\ 65%. GC: 99.7%. MW\ 782 g,
m.p.\ 91 ¡C. 1H NMR (d, 2.5 (tt, 2H, Hz,CDCl3) : 3JHH \ 7.8Hz, 3.1 (td, 8H, Hz,3JHF\ 19.6 RFCH2), 3JHH \ 6.6 3JHP \Hz, 3.6 (t, 8H, Hz, 4.3 (td,6.7 NCH2), 3JHH \ 6.3 CH2OCH2),2H, Hz, Hz, 19F NMR (d,3JHH \ 7.8 3JHP\ 9.8 CH2OP).[81.3 [114.1 [122.3 (10F),CDCl3) : (CF3), (CF2CH2),[123.2 (2F), [124.1 (2F), [126.7 13C NMR (d,(CF3CF2).32.3 (td, Hz, Hz, 44.8CDCl3) : 2JCF \ 21.3 3JCP\ 5.7 RFCH2),(s, 57.4 (d, Hz, 67.1 (d,NCH2), 2JCP\ 5.0 CH2OP), 3JCP\ 5.5Hz, 31P NMR (d, 14.2. IR (m/cm~1) :CH2OCH2). CDCl3) :1250È1150 (PxO, CF), 978 (PN). Anal. calcd (%) for
C 30.69 ; H 2.56 ; N 1.79 ; P 3.96 ; found : CC20H20F21N2O4P:30.74 ; H 2.46 ; N 1.82 ; P 3.85.
[3-(F-Decyl)propyl ]dimorpholinophosphate, F10C3DMP.
3-(F-Decyl)propanol (10.4 mmol), 10.4 mmol of and 26OPCl3mmol of morpholine. Yield\ 52% after chromatography
(etherÈchloroformÈmethanol 4.5 : 5 : 0.5) and recrystallisation
in isooctane. MW \ 796 g, m.p.\ 89 ¡C. 1H NMR (d,
1.9 (m, 2H, 2.2 (m, 2H, 3.1 (td,CDCl3) : RFCH2), RFCH2CH2),8H, Hz, Hz, 3.6 (t, 8H,3JHH \ 6.6 3JHP\ 6.7 NCH2), 3JHH \Hz, 4.1 (td, 2H, Hz, Hz,6.3 CH2OCH2), 3JHH \ 7.8 3JHP \ 9.813C NMR (d, 21.9 (s, 27.7 (t,CH2OP). CDCl3) : RFCH2),44.8 (s, 63.9 (d, Hz,RFCH2CH2), NCH2), 2JCP \ 5.0 CH2OP),67.2 (d, Hz, 31P NMR (d,3JCP\ 5.5 CH2OCH2). CDCl3) :14.8.
Pentadecyldimorpholinophosphate, C15DMP. Pentadecanol
(25.5 mmol), 25.6 mmol of and 51.1 mmol of morphol-OPCl3ine. Yield\ 65%. MW\ 446 g, m.p. \ 45 ¡C. 1H NMR (d,
0.8 (t, 1.2 (m, 24 H), 1.6 (m, 3.1CDCl3) : CH3), CH2CH2OP),(td, 8H, Hz, Hz, 3.6 (t, 8H,3JHH \ 6.2 3JHP\ 2.7 NCH2),Hz, 3.9 (dt, 2H, Hz,3JHH \ 6.2 CH2OCH2), 3JHH \ 6.6Hz, 13C NMR (d, 14.2 (s,3JHP\ 6.9 CH2OP). CDCl3) : CH3),
22.8, 25.8, 29.3, 29.4, 29.6, 29.7, 32.0 (all s, 12 30.6 (d,CH2),Hz, 44.8 (s, 65.7 (d,3JCP\ 6 CH2CH2O), NCH2), 2JCP\ 5.5Hz, 67.3 (d, Hz, 31P NMRCH2OP), 3JCP\ 5.7 CH2OCH2).(d, 13.7. IR (m/cm~1) : 1260È1230 (PxO), 962 (PN),CDCl3) :2930È2850 (CH). Anal. calcd (%) for C 31.88 ;C23H47N2O4P:H 10.54 ; N 6.28 ; P 6.95 ; found : C 31.95 ; H 10.68 ; N 6.35 ; P
7.02.
Synthesis of the bis(perÑuoroalkyl)
monomorpholinophosphates, D(FnCm)MMPs
Bis [2-(F-hexyl)ethyl ]monomorpholinophosphate, D(F6C2)-
MMP. (8.38 g, 54.6 mmol) was dissolved in 100 ml ofOPCl3dry ether under dry nitrogen. 2-(F-Hexyl)ethanol (39.9 g, 109.6
mmol) and 10.2 g (14 mL, 112 mmol) of in 50 mL ofNEt3were added dropwise to this solution at 50 ¡C. TheEt2Omixture was stirred for 12 h at room temperature, Ðltered and
the solvent and the excess of amine were removed under
vacuum. Morpholine (10.1 g, 116 mmol) in 50 mL wasEt2Othen added dropwise at 0 ¡C. The reaction mixture was
reÑuxed and stirred for 12 h. The precipitate was then Ðltered,
washed with and the solvent evaporated. The crudeEt2Oproduct was puriÐed by column chromatography on silica
(gradient from 10% ethyl acetate in hexane to 100% ethyl
acetate). Recrystallisation from hexane yielded 30.4 g (65%
with respect to the Ñuorinated alcohol) of the Ðnal product.
MW \ 859 g, m.p.\ 48 ¡C. 1H NMR (d, 2.45 (m, 4H,CDCl3) :3.09 (m, 4H, 3.6 (m, 4H, 4.25RFCH2), CH2N), CH2OCH2),[m, 4H, 19F NMR (d, [81.3(CH2O)2PO]. CDCl3) : (CF3),[114.0 [122.4 (2F), [123.4 (2F), [124.1 (2F),(CF2CH2),[126.6 31P NMR (d, 8.34. IR (m/cm~1) :(CF3CF2). CDCl3) :1250È1150 (PxO, CF), 970 (PN). Anal. calcd (%) for
C 27.95 ; H 1.88 ; N 1.63 ; P 1.64 ; found : CC20H16F26NO4P:27.91 ; H 1.82 ; N 1.59 ; P 1.60.
Bis [2-(F-octyl)ethyl ]monomorpholinophosphate, D(F8C2)-
MMP. The same procedure was applied to 6.91 g (45.0 mmol)
of 41.82 g (90.2 mmol) of 2-(F-octyl)ethanol and 11.3OPCl3 ,mL (8.51 g, 90.3 mmol) of The reaction mixture, afterNEt3 .having been stirred for 12 h at room temperature, was
reÑuxed for 4 h. Morpholine (7.93 g, 91.1 mmol) was then
added at room temperature and the mixture was reÑuxed for
12 h and Ðltered. The precipitate was extracted with a
mixture. The ether and chloroform solutionsCHCl3ÈH2Owere removed and the combined residues were chromato-
graphed on silica with the same gradient as above. Rec-
rystallisation from hexane yielded 24.3 g (55%) of a white
material. MW\ 1059 g, m.p.\ 79 ¡C, 1H NMR (d, CDCl3) :2.55 (m, 4H, 3.19 (m, 4H, 3.7 (m, 4H,RFCH2), CH2N),4.33 [m, 4H, 19F NMR (d,CH2OCH2), (CH2O)2PO].[81.3 [114.2 [122.5 (4F),CDCl3) : (CF3), (CF2CH2),[123.4 (4F), [124.1 (2F), [126.6 31P NMR (d,(CF3CF2).8.29. IR (m/cm~1) : 1250È1150 (PxO, CF), 970 (PN).CDCl3) :Anal. calcd (%) for C 27.20 ; H 1.52 ; NC24H16F34NO4P:1.32 ; P 2.92 ; found : C 27.22 ; H 1.50 ; N 1.36 ; P 2.90.
Bis [1-(F-nonyl)methyl ]monomorpholinophosphate,D(F9C1)-
MMP. The same procedure as for D(F8C2)MMP, when
applied to 1.93 g (45.0 mmol) of 41.84 g (90.2 mmol)OPCl3 ,of 1-(F-nonyl)methanol, 11.3 mL (8.51 g, 90.3 mmol) of NEt3and, subsequently, 7.93 g (91.1 mmol) of morpholine, yielded
5.42 g (37%) of D(F9C1)MMP. MW\ 1131 g, m.p.\ 82 ¡C.
1H NMR (d, 3.2 (m, 4H, 3.65 (m, 4H,CDCl3) : CH2N),4.2 [m, 4H, 19F NMR (d,CH2OCH2), (CH2O)2PO]. CDCl3) :
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[81.5 [114.1 [122.5 (4F), [123.4 (6F),(CF3), (CF2CH2),[124.2 (2F), [126.5 31P NMR (d, 8.35.(CF3CF2) ; CDCl3) :IR (m/cm~1) : 1250È1150 (PxO, CF), 970 (PN). Anal. calcd
(%) for C 25.48 ; H 1.07 ; N 1.24 ; P 2.90 ;C24H16F34NO4P:found : C 25.12 ; H 0.99 ; N 1.25 ; P 2.60.
Results and Discussion
Synthesis
The series of (perÑuoroalkyl)alkyldimorpholinophosphate sur-
factants has been extended ; the yields were in the 52È73%
range. The procedure consists, in its Ðrst step, in the phos-
phorylation of the Ñuorinated alcohol by phosphorus oxy-
chloride as shown in Scheme 1. The formation of di- and
triesters and the chlorination of the alcohol can be avoided by
using dry ether and an excess of triethylamine, which result in
the precipitation of triethylammonium chloride.17 The
(perÑuoroalkyl)alkyldimorpholinophosphates were subse-
quently obtained by reaction with morpholine. Ca. 5% of the
crude material obtained consisted of a by-product, which was
identiÐed by NMR to be the diester D(FnCm)MMP. No pyro-
phosphate was detected. The stability of the FnCmDMPs was
assessed by heating aqueous solutions of these compounds (10
Scheme 1 Synthesis of (F-alkyl)alkyldimorpholinophosphates and
bis[(F-alkyl)alkyl]monomorpholinophosphates
g L~1) for 18 h. After evaporation of the water, the residue
was dissolved in and analysed by 1H and 31P NMR.CDCl3No degradation of the products was detected.
The synthesis of bis[(F-alkyl)alkyl]monomorpho-
linophosphates also involve the direct phosphorylation of
the F-alkylated alcohols by followed by reaction withOPCl3 ,morpholine. However, the duration of the Ðrst step was
increased because of steric crowding due to the presence of
two bulky and rigid perÑuoroalkylated chains. In the case of
D(F8C2)MMP and D(F9C1)MMP, heating at reÑux was even
necessary to achieve phosphorylation of the alcohols. Further-
more, two equivalents of morpholine without triethylamine
were needed : it was impossible to obtain the D(FnCm)MMPs
with only one equivalent of morpholine in the presence of an
excess of triethylamine as in the case of the dimorpholinop-
hosphates. This can be explained by a competition between
the two bases for the remaining, crowded and less reactive
PwCl bond. With the procedure reported here, the
D(FnCm)MMPs could be obtained in 37È65% yield.
Surface and interfacial tension measurements
It is well-known that Ñuorinated surfactants are much more
surface active at the air/water interface than standard hydro-
genated surfactants.1h4,18,19 We have assessed the surface
activity of the perÑuoroalkylated mono- and dimorpholino-
phosphates by measuring the surface tension, of theircs ,aqueous solutions and the interfacial tension between these
solutions and perÑuorodecalin, Long equilibrationci(FDC).times (several hours) were necessary, especially for the sur-
factants with the highest Fn : Cm ratio, in order to reach equi-
librium.20 The results are collected in Table 1. It can be seen
that the FnCmDMPs can reduce the surface tension of water
from 72 to 21.2È24.5 mN m~1, even when they are very short,
as in the case of F4C2DMP. In comparison, the hydrogenated
analogues, C10DMP and C15DMP, are much less e†ective
and reduce the of water to 30È32.5 mN m~1 only, evencswhen higher concentrations of the surfactant (e.g. 10~4 mol
L~1) are used. The length of the hydrophobic chain has only a
small impact on the surface tension value at the critical micel-
lar concentration (cmc), in line with other results on nonionic
surfactants.21 The cmc of the Ñuorinated products are very
low and decrease, as expected, when the degree of Ñuorination
and/or the hydrocarbon spacer length increase. It is well-
known that Ñuorinated surfactants have a higher tendency to
form micelles than hydrogenated analogues.18,19 The cmc
value of F8C2DMP is ca. two orders of magnitude lower than
that of C10DMP. On the other hand, it was found that for a
given length of the Ñuorinated chain, increasing the length of
the hydrogenated spacer did not lower the cmc value as much
as would have been expected ; see for example the cmc of
F6C2DMP and F6C11DMP (97.3] 10~6 and 25.4] 10~6
mol L~1, respectively). This observation may indicate that it is
the length of the Ñuorinated chain that actually controls
micellization and that the spacer only plays a minor role.22
The Ñuorinated FnCmDMPs were also found to reduce the
interfacial tension between water and perÑuorodecalin very
e†ectively, i.e. from 56 to ca. 1 mN m~1, while their hydro-
genated analogues reduce only to 10 mN m~1.ciThe D(FnCm)MMPs were found to be less-surface active
than the FnCmDMPs. D(F6C2)MMP reduces the surface
tension of water to 23.5 mN m~1 but only at concentrations
higher than 1.5] 10~5 mol L~1. Likewise, high concentra-
tions were needed to reduce the interfacial tension between
water and perÑuorodecalin (FDC) signiÐcantly mN(ci \ 12.5m~1 at 10~2 mol L~1). D(F6C2)MMP being soluble in FDC,
a signiÐcant amount of the surfactant remains in the form of
monomers, and is therefore not available to form the mono-
layer. The high interfacial tension values obtained with
D(F8C2)MMP and D(F9C1)MMP mN m~1 and(ci\ 15.5
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Table 1 Surface and interfacial tensions of aqueous solutions of perÑuoroalkylated dimorpholinophosphates and monomorpholinophosphates
at 25 ¡C and biological data
Acute toxicity in mice LD50
cmc/ cs/ c/ ci(FDC)/ i.v./ i.p./Compound mol L~1 mN m~1 mol L~1 mN m~1 mg (kg body weight)~1 Survival g (kg body weight)~1 Survival
F4C2DMP 3.2] 10~3 24.5 8.3 ] 10~3 3.7 [500 10/10 È È
F6C2DMP 1.0] 10~4 22.0 3.2 ] 10~3 2.3 [250 10/10 È È
F6C11DMP 2.6] 10~5 23.5 2.8 ] 10~4 0.9 [25 10/10 È È
F7C1DMP 1.5] 10~5 21.2 2.0 ] 10~3 3.7 È È È È
F8C2DMP 2.0] 10~6 22.5 1.5 ] 10~4 0.9 [25 10/10 [2 10/10
F8C5DMP 8.9] 10~7 22.5 6.9 ] 10~5 3.8 È È B2 5/10
F8C11DMPa 1.0] 10~6 23.0 È È [2000 10/10 B4 5/10
F9C1DMP 7.7] 10~7 23.0 2.5 ] 10~3 0.9 È È È È
F10C2DMPb 1.0] 10~6 23.5 È È È È È È
C10DMP 2.5] 10~4 30.0 È È [140 10/10 È È
C15DMP 1.6] 10~6 32.5 5.4 ] 10~5 9.4 È È È È
D(F6C2)MMP 1.5] 10~5 23.5 1.7 ] 10~2 12.7 È È [4 8/10
D(F8C2)MMPb 2.1] 10~6 23.5 1.0 ] 10~2 15.5 È È È È
D(F9C1)MMPb 1.0] 10~5 25.3 9.9 ] 10~3 14.5 È È [2 9/10
a Calculated. b Measured at 60 ¡C.
mN m~1 at 10~2 mol L~1), which are very solubleci\ 14.5in the Ñuorocarbon phase, conÐrm this view. The quasi-
insolubility of the monomorpholinophosphates in water
explains that D(F8C2)MMP and D(F9C1)MMP reduce the
surface tension of water to 23.5 and 25.3 mN m~1, respec-
tively, but only at 60 ¡C.
Acute toxicity and hemolysis data
The preliminary biological tests performed on the new per-
Ñuoroalkylated amphiphiles are collected in Table 1. Disper-
sions of F6C2DMP, F6C11DMP, F8C2DMP and
F8C11DMP (0.05 to 0.5 g L~1 in 0.9% of NaCl) did not
perturb the growth and viability of Namalva strain lympho-
blastoid cell cultures, while a solution of the non-Ñuorinated
analogue C10DMP (0.05 g L~1) totally inhibited cell growth
and viability.7 Likewise, solutions of the Ñuorinated sur-
factants did not show any hemolytic activity on a suspension
of human red blood cells : in contrast, a solution of C10DMP
(0.5 g L~1) was strongly hemolytic.
Aqueous dispersions of the above Ñuorinated surfactants
were well-tolerated when administered intravenously (tail
vein) in mice ; the i.v. values were higher than 200È250LD50mg (kg body weight)~1 (10/10 survivals) for F6C2DMP and
F8C2DMP (limit of protocol/solubility). To increase the
amount of surfactant that could be administered, we prepared
a dispersion of the poorly water-soluble F8C11DMP in 0.9%
NaCl using egg yolk phospholipids. The toxicity tests indi-
cated a value higher than 2 g (kg body weight)~1 (limitLD50of protocol, 10/10 survivals).
Intraperitoneal administration in mice of FnCmDMPs in
perÑuorooctyl bromide (PFOB) gave values higher thanLD502 g (kg body weight)~1 for F8C2DMP (10/10 survivals) and
around 4 g (kg body weight)~1 for F8C11DMP (5/10
survivals). Very encouraging results have also been obtained
for the bis-perÑuoroalkylated monomorpholinophosphates
with i.p. values larger than 4 and 2 g (kg bodyLD50weight)~1 for D(F6C2)MMP (8/10 survivals) and
D(F9C1)MMP (9/10 survivals), respectively.
All these results conÐrm that in spite of their high surface
activity, Ñuorinated morpholinophosphates are well tolerated
by cell cultures, are non-hemolytic, and present low to very
low acute toxicity, even when administered intravascularly.
They conÐrm our opinion that perÑuoroalkylated
morpholinophosphates have potential as components of col-
loidal systems intended for biomedical applications.
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